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Abstract
Objective: To develop a pediatric research agenda focused on pediatric healthcare-associated infections and antimicrobial stewardship topics
that will yield the highest impact on child health.
Participants: The study included 26 geographically diverse adult and pediatric infectious diseases clinicians with expertise in healthcareassociated infection prevention and/or antimicrobial stewardship (topic identification and ranking of priorities), as well as members of
the Division of Healthcare Quality and Promotion at the Centers for Disease Control and Prevention (topic identification).
Methods: Using a modified Delphi approach, expert recommendations were generated through an iterative process for identifying pediatric
research priorities in healthcare associated infection prevention and antimicrobial stewardship. The multistep, 7-month process included a
literature review, interactive teleconferences, web-based surveys, and 2 in-person meetings.
Results: A final list of 12 high-priority research topics were generated in the 2 domains. High-priority healthcare-associated infection
topics included judicious testing for Clostridioides difficile infection, chlorhexidine (CHG) bathing, measuring and preventing hospital-onset
bloodstream infection rates, surgical site infection prevention, surveillance and prevention of multidrug resistant gram-negative rod
infections. Antimicrobial stewardship topics included β-lactam allergy de-labeling, judicious use of perioperative antibiotics, intravenous
to oral conversion of antimicrobial therapy, developing a patient-level “harm index” for antibiotic exposure, and benchmarking and or peer
comparison of antibiotic use for common inpatient conditions.
Conclusions: We identified 6 healthcare-associated infection topics and 6 antimicrobial stewardship topics as potentially high-impact targets
for pediatric research.
(Received 5 March 2020; accepted 29 July 2020)
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The burden of healthcare-associated infections (HAIs) among
hospitalized infants and children is substantial and approximates
rates reported in adults. A point-prevalence survey conducted in
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199 hospitals in 2015 demonstrated that the rate of HAI in children
aged 1–17 years was similar to that observed in patients
aged ≥18 years (2.5% vs 3.5%).1 Although the risks of an HAI
are similar among children and adults, few pediatric studies
support evidence-based prevention strategies. Importantly, several
observations demonstrate why evidence derived from adult studies
cannot always be applied to children.6 First, the spectrum of HAIs
experienced by pediatric patients differs significantly from that
experienced by adult patients. For example, respiratory viral
infections are one of the leading causes of pediatric HAIs and cause
significant morbidity and mortality in vulnerable pediatric populations, but this HAI is rarely identified in hospitalized adults.7
Second, many HAI prevention strategies that have been developed
and tested in adult populations cannot be easily implemented
in the pediatric healthcare setting. Developmentally appropriate
behaviors make interventions, such as a daily sedation vacation,
impracticable and potentially unsafe in young children who
require invasive mechanical ventilation. Third, the types of HAI,
risk factors for HAI, and HAI prevention strategies may even differ
over the age-spectrum pediatric patients, which ranges from verylow-birth-weight, preterm infants to adolescents.
Despite growing recognition that overuse is the primary driver
of antimicrobial resistance, an estimated 60% of hospitalized children receive antimicrobial agents, including >90% of children who
undergo surgery or require critical care.3 Numerous studies have
suggested that as much as half of antibiotic use in both inpatient
and outpatient settings is not indicated.4,5 To address this, national
guidelines recommend that both adult and pediatric hospitals
conduct antimicrobial stewardship (AS). Although the general
principles of stewardship are shared across patient populations
and settings, application of these principles to pediatrics requires
consideration of important differences between adult and pediatric
patients. For example, appendicitis, cystic fibrosis, and neonatal
fever are some of the most common indications for antibiotic
use in children’s hospitals. For infections that are commonly identified in both children and adults, such as pneumonia, urinary tract
infections, and cellulitis, the selection and pharmacokinetics of
antibiotics often differ.8
A pediatric research agenda is needed to focus on pediatric
HAIs and AS questions that will yield the highest possible
impact on child health. The Centers for Disease Control and
Prevention (CDC)–sponsored Prevention Epicenters Program is
a collaborative network of academic investigators conducting
innovative infection prevention and control as well as AS research.
The University of Pennsylvania/Children’s Hospital of Philadelphia
Prevention Epicenter convened a network of investigators composed
of pediatric HAI and AS expert clinicians, researchers, and stakeholders in the spring of 2018 to discuss gaps in evidence and identify
priorities to inform the field of pediatric HAI and AS research.
Methods and Results
Overview
A working group of experts in pediatric HAI prevention and
AS research and operations convened in the spring of 2018 to
discuss potential priority topics for pediatric research in these
fields. We surveyed attendees using a modified Delphi approach
to generate expert opinions regarding the highest priority research
topics in these 2 domains. The iterative process included a
literature review, 3 teleconferences, 3 web-based surveys, and
2 in-person meetings. Throughout the process, attendees were
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encouraged to provide feedback and suggest additional approaches
to ranking pediatric priorities for HAI and AS research in inpatient
and outpatient settings.
Reviewing recent literature
Using Medline, the group leaders (S.E.C. and J.S.G.) conducted a
comprehensive literature review of peer-reviewed, English-language
articles published from January 2010 to June 2018 related to pediatric
HAI and AS. The following search terms were used: healthcareassociated infections, drug-resistant organisms, antimicrobial resistance, and antimicrobial stewardship. Topics were limited by using
the filter “child: age <18 years.” Experts also submitted additional
publications considered relevant for inclusion. Title and abstract
reviews were undertaken to ensure relevance to human health and
to exclude case reports. A bibliography including titles and abstracts
of identified articles was constructed by sorting articles into the following domains: infection prevention/HAI, device-related infections,
multidrug-resistant organisms, neonatal HAI/AS, viral HAI, and AS.
Our search identified 295 English-language publications related to
pediatric HAI and AS. The structured bibliography was shared with
expert panelists to ensure a shared understanding of the current body
of relevant literature.
Expert participants
Authors S.E.C. and J.S.G. invited 26 experts to participate
from geographically diverse institutions with research and clinical
operations expertise in HAI or AS to participate in the process
(Appendix 1 online). As sponsors of the Epicenters Program with
expertise in HAIs and AS issues from a public health perspective,
members of the Division of Healthcare Quality and Promotion at
CDC also participated in the topic identification but not in the
ranking of priorities.
Soliciting topic ideas
Each expert completed an open-ended REDCap survey asking
about potential priority topics for pediatric HAI and AS research.
For each topic, the expert was asked to provide a brief rationale,
approach to study design, feasibility, and potential overall cost.
In total, 15 topic ideas were submitted, many of which overlapped.
Ranking: Round 1
The group leaders created a risk assessment table by compiling
topics identified by the literature review and by the experts. An initial 55 topic submissions were aggregated into 28 topics. Prior
to expert ranking, 16 HAI topics were grouped into 4 categories
(antibiotic resistant organisms, HAIs, metrics, and other topics),
and 12 AS topics were presented without grouping. Major HAI
topics included resistant gram-negative organisms, surgical site
infections, and Clostridioides difficile infections. AS topics included
overuse of broad-spectrum therapy in inpatient settings, short
course therapy in inpatient and outpatient settings, and rapid
diagnostics (Appendix 2 online). A second REDCap survey was
then distributed, asking experts to rank each topic on 3 attributes:
magnitude, impact, and research opportunity: 1 (low) to 3 (high).
For each topic, the mean score was calculated for each attribute,
then the 3 mean values were multiplied to obtain a final score.
Experts were also asked to identify a specific target population
for each topic.

Downloaded from https://www.cambridge.org/core. 14 Jan 2021 at 00:19:27, subject to the Cambridge Core terms of use.

Infection Control & Hospital Epidemiology

Ranking: Round 2
Experts attended a 1-day, in-person meeting to refine the prioritization of pediatric HAI and AS research topics. After presenting
the results of the first round of ranking, several experts presented
key published articles that focused on gaps in pediatric HAI and AS
research. Experts were then grouped by their major domain of
research (HAI or AS) to discuss the results of voting in round 1.
Each group was asked to identify the top 10 priority topics in their
domain. Thereafter, all participants convened to share perspectives. An additional round of ranking was then conducted using
Poll Everywhere (San Francisco, CA), a web-based participantresponse system. Each expert voted privately on their ranking
of the 13 HAI topics, and 15 AS topics advanced after group
discussions. Experts were asked to rank HAI and AS topics from
highest priority lowest priority; HAI and AS lists were ranked
independently.

3

Table 1. Final Pediatric Research Priorities Ranked by Final Payoff Matrix Score
Payoff Matrixa

Healthcare-Associated Infection Topic

Feasible and high impact

Diagnostic stewardship interventions for
Clostridioides difficile
Chlorhexidine (CHG) bathing to decrease
multidrug-resistant organism acquisition
in hospitalized children
Developing a metric to define hospital-onset
bloodstream infection

Low feasibility but high
impact

Molecular epidemiology and transmission
dynamics of multidrug-resistant
gram-negative rods in critically ill children
Novel central-line–associated bloodstream
infection prevention bundles for high-risk
pediatric populations

Payoff matrix
After the in-person meeting, we recognized the need for further
refinement of prioritization schemes because many topics in both
domains were tightly clustered with similar composite ranking
scores. We used a “payoff matrix” that assessed the magnitude
of impact and ease of conducting research for each topic.9
Participants assigned each topic into 1 of 4 categories: group 1 (feasible
and high-impact), group 2 (low feasibility but high-impact), group 3
(feasible, but low-impact) and group 4 (low feasibility and low-impact).
Experts were sent a remote link to complete this payoff matrix for
each of the 13 HAI topics and 15 AS topics established at the June
2018 in-person meeting.
Using the “payoff matrix” led to a substantial reordering of priorities among HAI topics based on the assessment of “feasible and
high-impact” compared with “low-feasibility, but high-impact”
(Table 1). Two HAI topics that had received relatively lower overall
rankings (ie, chlorhexidine bathing to reduce colonization with
drug-resistant organisms and developing a hospital-onset bloodstream infection metric) were included in the 3 topics categorized
as “feasible and high impact.” Three HAI projects were considered
“feasible and high impact.” These included the evaluation of a diagnostic stewardship bundle to reduce the inappropriate diagnosis of
C. difficile infection, the development of a new metric for healthcare-onset bloodstream infections, and the assessment of antiseptic
bathing to prevent colonization and infection with MDROs in various pediatric populations. In contrast, the relative priority rankings
of antimicrobial resistance and AS topics were not substantially
changed by the application of the payoff matrix. The 4 AS projects
were considered “feasible and high impact.” These included β-lactam allergy delabeling in low-risk outpatients, judicious use of perioperative antibiotics, shortening the duration of antibiotic therapy
for common infections, and increased use of oral (instead of intravenous) antimicrobial therapy.
Final selection of topics
After the results of the payoff matrix voting were available, 2 teleconferences for attendees were convened. The HAI expert group
developed consensus that the top 6 research topics should be considered high priority. The AS expert group identified 9 research
topics from the payoff matrix and chose to re-rank them using
additional participant voting; the group developed consensus that
the top 6 should be considered high priority.

Surgical site infection prevention for
specific high-risk pediatric procedures:
ventriculo-peritoneal shunts; spinal fusion
with instrumentation; cardiothoracic surgery

Feasible and high impact

β-lactam allergy de-labeling in low-risk
outpatients
Judicious use of perioperative antibiotics
Shorten duration of antibiotic therapy for
common bacterial infections
Increased use of oral (instead of intravenous) therapy

Low feasibility but high
impact

Develop patient-level “harm index” of
antibiotics
Benchmarking and/or peer comparisons
of antibiotic use for common inpatient
conditions

a
Topics categorized as “feasible, but low impact” or “low feasibility and low impact” in the
payoff matrix removed.

Discussion
To identify gaps in evidence and opportunities for impactful
research, we leveraged available data, individual expertise, and
structured discussion to identify and prioritize topics for pediatric
HAI and AS research. Serial voting, using the Delphi process, was
employed to focus and categorize identified topics by relative priority and level of difficulty performing the evaluation. This process
generated 6 HAI and 6 AS topics as high priority targets for future
research.
Ultimately, 3 HAI and 4 AS projects were considered high
impact and feasible to initiate. The perceived ease of executing
the HAI projects was likely related to the fact that most of the
key data elements were routinely captured as part of clinical care.
In contrast, the need to secure substantial funding and solidify
a multicenter research network, led 2 high-priority HAI topics,
both related to identifying the reservoirs and transmission patterns
of multidrug-resistant gram-negative organisms, to be categorized
as projects with “low feasibility but high impact.” The perceived
ease of executing the 4 identified AS projects was likely related to
the large numbers of relevant patient encounters and readily available
clinical data required to study these topics. Alternatively, developing
a patient-level “harm index” of antibiotics and benchmarking and/or
peer comparisons for treating common inpatient conditions were
identified as “low feasibility but high impact” due to the more challenging nature of establishing definitions, data collection, and analytic approaches.
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Several barriers limited our efforts to identify pediatric priorities for HAI and AS research. Most participants were affiliated
with an academic children’s facility. Although most complex
inpatient pediatric care is delivered at tertiary-care and academically affiliated centers, our experience with pediatric care delivered
in community hospitals was limited. Similarly, we had fewer
participants with research and practice experience in outpatient
pediatrics, although much of pediatric care is delivered in ambulatory settings.
In summary, we reviewed the published literature and leveraged
the knowledge of content experts with contributions by and guidance from CDC colleagues. This systematic approach to building
expert opinion identified specific HAI and AS research topics that
are most likely to have a substantial positive impact on the health
outcomes of children.
Supplementary material. To view supplementary material for this article,
please visit https://doi.org/10.1017/ice.2020.1267
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